10x Genomics (TXG) Return on Invested Capital (2019 - 2020)
10x Genomics (TXG) posted Return on Invested Capital of 0.1% for Q3 2020, down 120.54% sequentially from 0.04% in Q2 2020, and up 3.0% YoY from 0.1% in Q4 2019.
10x Genomics (TXG) Return on Invested Capital (2019 - 2020) Analysis & Trends
10x Genomics has reported Return on Invested Capital for 2 years, with the latest figure at 0.1% in Q3 2020.
- Quarterly Return on Invested Capital rose 3.0% year-over-year to 0.1% in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.1% (up 3.0% YoY) and the FY2019 annual result came in at 0.04%, changed N/A from the prior year.
- Return on Invested Capital declined to 0.1% in Q3 2020 per TXG's latest filing, from 0.04% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.02% in Q4 2019 and troughed at 0.12% in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 0.02% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 0.05% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -0.10% |
| Jun 30, 2020 | -0.04% |
| Mar 31, 2020 | -0.03% |
| Dec 31, 2019 | -0.02% |
| Sep 30, 2019 | -0.12% |